PROLOR Biotech (PBTH)
Create an Alert
6.30
-0.09 -1.41%
AMEX
Jun 19, 5:00PM
BATS Real time
Currency in USD
PROLOR Biotech SG&A Expense Quarterly:
1.531M for March 31, 2013PROLOR Biotech Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.531M |
| Dec. 31, 2012 | 0.2172M |
| Sept. 30, 2012 | 0.8666M |
| June 30, 2012 | 0.8587M |
| March 31, 2012 | 0.7898M |
| Dec. 31, 2011 | 0.3489M |
| Sept. 30, 2011 | 0.8083M |
| June 30, 2011 | 0.878M |
| March 31, 2011 | 0.7089M |
| Dec. 31, 2010 | 0.4492M |
| Sept. 30, 2010 | 0.6451M |
| June 30, 2010 | 0.6426M |
| March 31, 2010 | 0.4855M |
| Dec. 31, 2009 | 0.527M |
| Sept. 30, 2009 | 0.4019M |
| June 30, 2009 | 0.4943M |
| March 31, 2009 | 0.4787M |
| Dec. 31, 2008 | 0.6478M |
| Sept. 30, 2008 | 0.5408M |
| June 30, 2008 | 0.6126M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
PBTH SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Array BioPharma | 5.001M |
| GTx | 3.023M |
| Opko Health | 12.42M |
PBTH SG&A Expense Quarterly Rankings
| Overall |
62nd percentile 6310 of 16782 |
| Sector |
54th percentile 646 of 1410 in Healthcare |
| Industry |
54th percentile 207 of 454 in Biotechnology |
PBTH SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 0.2172M | Dec 2012 |
| Maximum | 1.531M | Mar 2013 |
| Average | 0.6466M |
